首页> 外文期刊>JAMA: the Journal of the American Medical Association >Empirical validation of guidelines for the management of pharyngitis in children and adults.
【24h】

Empirical validation of guidelines for the management of pharyngitis in children and adults.

机译:对儿童和成人咽炎管理指南的经验验证。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Recent guidelines for management of pharyngitis vary in their recommendations concerning empirical antibiotic treatment and the need for laboratory confirmation of group A streptococcus (GAS). OBJECTIVE: To assess the impact of guideline recommendations and alternative approaches on identification and treatment of GAS pharyngitis in children and adults. DESIGN, SETTING, AND PARTICIPANTS: Throat cultures and rapid antigen tests were performed on 787 children and adults aged 3 to 69 years with acute sore throat attending a family medicine clinic in Calgary, Alberta, from September 1999 to August 2002. Recommendations from 2 guidelines (those of the Infectious Diseases Society of America and of the American College of Physicians-American Society of Internal Medicine/American Academy of Family Physicians/US Centers for Disease Control and Prevention) were compared with rapid testing alone, a clinical prediction rule (ie, the modified Centor score), and a criterion standard of treatment for positive throat culture results only. MAIN OUTCOME MEASURES: Sensitivity and specificity of each strategy for identifying GAS pharyngitis, total antibiotics recommended, and unnecessary antibiotic prescriptions. RESULTS: In children, sensitivity for streptococcal infection ranged from 85.8% (133/155; 95% confidence interval [CI], 79.3%-90.0%) for rapid testing to 100% for culturing all. In adults, sensitivity ranged from 76.7% (56/73; 95% CI, 65.4%-85.8%) for rapid testing without culture confirmation of negative results to 100% for culturing all. In children, specificity ranged from 90.3% (270/299; 95% CI, 86.4%-93.4%) for use of modified Centor score and throat culture to 100% for culturing all. In adults, specificity ranged from 43.8% (114/260; 95% CI, 37.7%-50.1%) for empirical treatment based on a modified Centor score of 3 or 4 to 100% for culturing all. Total antibiotic prescriptions were lowest with rapid testing (24.7% [194/787]; 95% CI, 21.7%-27.8%) and highest with empirical treatment of high-risk adults (45.7% [360/787]; 95% CI, 42.2%-49.3%), due to a high rate of unnecessary prescriptions in adults (43.8% [146/333]; 95% CI, 38.4%-49.4%). CONCLUSIONS: Guideline recommendations for the selective use of throat cultures but antibiotic treatment based only on positive rapid test or throat culture results can reduce unnecessary use of antibiotics for treatment of pharyngitis. However, empirical treatment of adults having a Centor score of 3 or 4 is associated with a high rate of unnecessary antibiotic use. In children, strategies incorporating throat culture or throat culture confirmation of negative rapid antigen test results are highly sensitive and specific. Throat culture of all adults or those selected on the basis of a clinical prediction rule had the highest sensitivity and specificity.
机译:背景:关于咽炎的最新治疗指南在有关经验性抗生素治疗的建议以及对A组链球菌(GAS)进行实验室确认的需求方面存在差异。目的:评估指南建议和替代方法对儿童和成人GAS咽炎的识别和治疗的影响。设计,地点和参与者:1999年9月至2002年8月,在亚伯大省卡尔加里的一家家庭医学诊所对787名3至69岁的儿童和成人进行了喉咙培养和快速抗原检测。 (美国传染病学会和美国内科医师学会/美国内科医师学会/美国家庭医师学会/美国疾病控制与预防中心的研究人员)与单独的快速检测(一种临床预测规则(即,修改后的Centor得分)以及仅针对阳性咽喉培养的治疗标准。主要观察指标:每种鉴别GAS咽炎的策略的敏感性和特异性,推荐的抗生素总量和不必要的抗生素处方。结果:在儿童中,对链球菌感染的敏感度范围从快速检测的85.8%(133/155; 95%置信区间[CI],79.3%-90.0%)到全部培养的100%不等。在成人中,无需培养确认阴性结果的快速检测灵敏度范围为76.7%(56/73; 95%CI,65.4%-85.8%)至100%均可培养。在儿童中,使用改良的Centor评分和喉咙培养的特异性范围从90.3%(270/299; 95%CI,86.4%-93.4%)到100%全部培养。在成人中,根据改良的Centor评分(3或4至100%),经验性治疗的特异性范围为43.8%(114/260; 95%CI,37.7%-50.1%)。快速测试的总抗生素处方最低(24.7%[194/787]; 95%CI,21.7%-27.8%),而对高危成年人进行实证治疗最高(45.7%[360/787]; 95%CI, 42.2%-49.3%),原因是成人中不必要处方的比例很高(43.8%[146/333]; 95%CI,38.4%-49.4%)。结论:有选择地使用咽喉培养物的指南建议,但仅基于阳性快速检测或咽喉培养结果的抗生素治疗可以减少不必要的抗生素治疗咽炎的使用。但是,对Centor评分为3或4的成年人进行经验性治疗会导致不必要的抗生素使用率很高。在儿童中,结合喉部培养或确认快速抗原测试结果阴性的喉部培养的策略高度敏感且具有特异性。在所有成年人或根据临床预测规则选择的成年人中,咽喉培养物具有最高的敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号